EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pilot Study of Immediate Lymphatic Reconstruction (ILR) During Lymph Node Dissection for Node‐Positive Melanoma: Feasibility, Safety, and Early Outcomes

Eva Lindell Jonsson iD, W K Fraser Hill, Marielle Saayman, Spencer Yakaback, Golpira Elmi Assadzadeh, E J Gregory McKinnon, Claire Temple-Oberle

Journal of Surgical Oncology · 2026

DOI: 10.1002/jso.70127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2026. Verfasst von Eva Lindell Jonsson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Plastic Surgery, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Melanoma, Lymph Node Excision, Lymphedema, Plastic Surgery Procedures. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Lymphedema (LE) is chronic swelling due to inadequate lymphatic function, which can occur after therapeutic lymph node dissection (TLND) for melanoma. At our institution, the risk of LE is 12% for axillary and 38% for ilioinguinal lymph node dissection. This study investigated LE rates in patients undergoing TLND with immediate lymphatic reconstruction (ILR) using lymphaticovenous anastomosis (LVA), a microsurgical technique aimed at preventing LE.

Methods

Patients with melanoma requiring TLND were recruited prospectively from the Tom Baker Cancer Center and were consented to undergo ILR at the time of their node dissection. Institutional ethics board approval was obtained (Ethics ID HREBA. cc‐20‐9426). This study was not a registered clinical trial; the ongoing randomized LYMbR trial (NCT05136079) is registered but does not include this cohort. The main objective was to assess the development of LE, which was defined as a 10% increase in postsurgical limb volume compared with the contralateral limb. In addition, participants completed the Lymphoedema Quality of Life Questionnaire (LYMQoL), a validated LE‐specific quality of life patient‐reported outcome measure (PROM) before surgery and at each 6‐month assessment, to assess for any changes in quality of life related to LE. A direct comparison was made to historical institutional rates of LE after TLND without ILR. Kaplan‐Meier analysis assessed overall survival and lymphedema‐free survival, while Mann‐Whitney U test compared quality of life between patients with and without lymphedema.

Results

Between August 2020 and October 2022, 22 patients (14 men and 8 women) with a median age of 68 (range 43–80) were included in the study and underwent TLND for melanoma with ILR. 16 patients underwent ALND, and 6 patients underwent ILND with ILR. There were no complications directly related to the ILR part of the procedure. All disease was at least stage III. At a median follow‐up of 34 months (range: 0−51 months), three patients met the criteria for LE, one who underwent ALND and two ILND. Of these three patients, two had regional recurrence and one suffered from a DVT and a postoperative wound infection in the affected limb. LYMQoL scores were equal or better (p = NS) in patients without LE than those with LE across all domains except for mood: function (median IQR 1.0 vs 1.0, p = 0.78), appearance (1.0 vs 1.6, p = 0.19), symptom burden (1.1 vs 1.6, p = 0.52), and mood (1.1 vs 1.0, p = 0.87).

Conclusion

This study aligns with other cohort studies demonstrating the usefulness of ILR in TLND patients with melanoma, which will be further examined in an ongoing randomized trial (LYMbR ‐ NCT05136079).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaLymph Node ExcisionLymphedemaPlastic Surgery ProceduresSkin NeoplasmsLymph NodesLymphatic VesselsHumansMaleFemaleMiddle AgedPilot ProjectsFeasibility StudiesAgedAdultQuality of LifeProspective StudiesAnastomosis, SurgicalFollow-Up StudiesAged, 80 and overLymphatic Metastasis

Stichwörter der Autor:innen

LVAimmediate lymphatic reconstructionindocyanine greenlymphatic reconstructionlymphaticovenous anastomosislymphedemalymphovenous anastomosismelanomatherapeutic lymph node dissection

Autor:innen und Institutionen

  • Division of Plastic Surgery, University of Calgary, Calgary, Alberta, Canada.
  • Division of Plastic Surgery and Maxillofacial Surgery, Uppsala University Hospital, Uppsala, Sweden.
  • Division of Surgical Oncology, Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Alberta, Canada.

ORCID-Profile: Eva Lindell Jonsson

Zitieren

APA

Jonsson, E. L., Fraser Hill, W. K., Saayman, M., Yakaback, S., Assadzadeh, G. E., Gregory McKinnon, E. J., & Temple-Oberle, C. (2026). Pilot Study of Immediate Lymphatic Reconstruction (ILR) During Lymph Node Dissection for Node‐Positive Melanoma: Feasibility, Safety, and Early Outcomes. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70127

Vancouver

Jonsson EL, Fraser Hill WK, Saayman M, Yakaback S, Assadzadeh GE, Gregory McKinnon EJ, et al. Pilot Study of Immediate Lymphatic Reconstruction (ILR) During Lymph Node Dissection for Node‐Positive Melanoma: Feasibility, Safety, and Early Outcomes. Journal of Surgical Oncology. 2026. doi:10.1002/jso.70127

BibTeX
@article{Jonsson2026,
  author = {Jonsson, Eva Lindell and Fraser Hill, W K and Saayman, Marielle and Yakaback, Spencer and Assadzadeh, Golpira Elmi and Gregory McKinnon, E J and Temple-Oberle, Claire},
  title = {Pilot Study of Immediate Lymphatic Reconstruction (ILR) During Lymph Node Dissection for Node‐Positive Melanoma: Feasibility, Safety, and Early Outcomes},
  journal = {Journal of Surgical Oncology},
  year = {2026},
  doi = {10.1002/jso.70127}
}
Kostenlos starten →